S. Muoio & Co’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

S. Muoio & Co’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$513K	Buy	+25,722	New	+$339K	0.68%	46

Other funds holding FMTX

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

S. Muoio & Co's FMTX Position: Q3 2022 in Review

S. Muoio & Co opened a new position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2022: 25,722 shares worth $513K. The stake represents 0.68% of the portfolio and ranks #46 among its holdings.

139 funds tracked by Wall St. Rank hold FMTX as of Q3 2022.

S. Muoio & Co held 25,722 shares of Forma Therapeutics Holdings, Inc. Common Stock worth $513K as of Q3 2022.
Forma Therapeutics Holdings, Inc. Common Stock was a new S. Muoio & Co position in Q3 2022.
Forma Therapeutics Holdings, Inc. Common Stock made up 0.68% of S. Muoio & Co's portfolio in Q3 2022, its #46 holding.
139 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on S. Muoio & Co's 13F filing for Q3 2022, filed 14 Nov 2022.